Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANDREW BLAUVELT

Allopathic & Osteopathic Physicians Dermatology

NPI
1932115425
CMS profile
314007
Location
PORTLAND, OR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$250,246.36

186 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $102,707.26 58
UCB, Inc. $76,160.60 67
LEO Pharma AS $21,888.68 8
ABBVIE INC. $9,063.91 9
GlaxoSmithKline, LLC. $7,800.00 2
Almirall LLC $5,801.44 3
SUN PHARMACEUTICAL INDUSTRIES INC. $5,578.35 9
GENZYME CORPORATION $5,270.35 6
Eli Lilly and Company $4,975.00 4
E.R. Squibb & Sons, L.L.C. $3,539.69 6
EMD Serono Research & Development Institute, Inc. $3,200.00 3
Celltrion, Inc. $2,400.00 1
LEO Pharma Inc. $1,241.93 6
Takeda Pharmaceuticals U.S.A., Inc. $399.00 1
Incyte Corporation $176.68 2
SANOFI US SERVICES INC. $43.47 1

Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANDREW BLAUVELT

NPI 1932115425 · CMS profile ID 314007

Allopathic & Osteopathic Physicians / Dermatology

PORTLAND, OR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1932115425?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANDREW BLAUVELT, NPI 1932115425, CMS profile ID 314007. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1932115425?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). ANDREW BLAUVELT, NPI 1932115425, CMS profile ID 314007. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1932115425?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
ANDREW BLAUVELT, NPI 1932115425, CMS profile ID 314007, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1932115425?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

186 matching records · $250,246.36 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 186 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 186.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
UCB, Inc. $90.2409/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224537508 CMS
UCB, Inc. $90.2409/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224537510 CMS
UCB, Inc. $123.4909/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224537512 CMS
UCB, Inc. $123.4909/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224537514 CMS
UCB, Inc. $381.4809/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224537516 CMS
UCB, Inc. $2,425.0009/25/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1224537518 CMS
UCB, Inc. $5,000.0009/25/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1224537520 CMS
UCB, Inc. $20.0009/24/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224537496 CMS
LEO Pharma Inc. $170.4109/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251993653 CMS
LEO Pharma Inc. $100.0009/19/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1251993650 CMS
SANOFI US SERVICES INC. $43.4709/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233247908 CMS
UCB, Inc. $115.3109/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224537494 CMS
UCB, Inc. $10.0009/09/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224537486 CMS
UCB, Inc. $10.0009/09/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224537488 CMS
UCB, Inc. $35.0009/09/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224537490 CMS
UCB, Inc. $35.0009/09/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224537492 CMS
UCB, Inc. $2,425.0008/28/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1224537484 CMS
GENZYME CORPORATION $955.0008/13/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233247880 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $227.9708/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1250968908 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $38.6608/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1250968910 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $32.0008/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1250968912 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $14.2808/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250968914 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $12.7208/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250968916 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $215.4808/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1250968918 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $187.2408/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1250968920 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $4,000.0008/08/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1250968922 CMS
LEO Pharma AS $905.0007/23/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1251988601 CMS
Lilly USA, LLC $2,250.0007/17/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1186502495 CMS
Lilly USA, LLC $3,600.0007/17/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1186509809 CMS
Lilly USA, LLC $479.6007/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1186502487 CMS
Lilly USA, LLC $28.6407/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186506749 CMS
UCB, Inc. $36.2607/10/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224537480 CMS
UCB, Inc. $5,000.0007/10/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1224537482 CMS
ABBVIE INC. $865.0007/08/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1201528306 CMS
Lilly USA, LLC $32.0006/23/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1186502493 CMS
Lilly USA, LLC $359.0006/23/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1186503793 CMS
Lilly USA, LLC $50.2906/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186506747 CMS
Lilly USA, LLC $3,600.0006/23/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1186507119 CMS
Lilly USA, LLC $71.0806/23/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1186507121 CMS
Lilly USA, LLC $3,600.0006/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1186507123 CMS
Lilly USA, LLC $2,250.0006/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1186509813 CMS
Lilly USA, LLC $3,600.0006/04/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1186471349 CMS
Lilly USA, LLC $3,150.0006/04/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1186480301 CMS
Lilly USA, LLC $19.0306/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186480305 CMS
Lilly USA, LLC $457.6506/04/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1186507103 CMS
UCB, Inc. $19.3105/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224537478 CMS
Lilly USA, LLC $130.3105/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1186503783 CMS
Lilly USA, LLC $177.0205/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1186506541 CMS
Lilly USA, LLC $48.4305/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186509811 CMS
UCB, Inc. $6,000.0005/30/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1224537476 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $272,256.22 220
PY2020 $193,582.40 91
PY2021 $182,403.33 53
PY2022 $324,768.01 199
PY2023 $313,199.33 207
PY2024 $263,916.05 196
PY2025 $250,246.36 186

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $3,000.00 3
PY2025 Principal investigator $30,177.96 4
PY2024 Recipient $4,640.00 4
PY2024 Principal investigator $278,265.77 51
PY2023 Recipient $12,706.32 17
PY2023 Principal investigator $1,327,456.43 257
PY2022 Recipient $34,260.97 27
PY2022 Principal investigator $5,382,753.42 283
PY2021 Recipient $51,322.53 88
PY2021 Principal investigator $3,157,339.68 418
PY2020 Recipient $92,690.93 100
PY2020 Principal investigator $2,933,277.15 305
PY2019 Recipient $54,230.13 56
PY2019 Principal investigator $3,889,967.94 274

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

7 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient GENZYME CORPORATION $1,250.00 12/08/2025 Covered Recipient Physician A Phase IIb, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Dose Ranging Study of a Subcutaneous Anti-OX40L Monoclonal Antibody (KY1005) in Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1226091535
Recipient GENZYME CORPORATION $500.00 09/19/2025 Covered Recipient Physician A Phase IIb, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Dose Ranging Study of a Subcutaneous Anti-OX40L Monoclonal Antibody (KY1005) in Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1226091519
Recipient GENZYME CORPORATION $1,250.00 09/01/2025 Covered Recipient Physician A Phase IIb, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Dose Ranging Study of a Subcutaneous Anti-OX40L Monoclonal Antibody (KY1005) in Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1226091525
Principal investigator 1 ABBVIE INC. $20,000.00 03/27/2025 Non-covered Recipient Entity
OREGON MED RESEARCH CTR P
High Dose Risankizumab for Psoriasis No dispute reported 06/30/2026 1202466517
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $1,568.45 03/03/2025 Non-covered Recipient Entity
OREGON MEDICAL RESEARCH CENTER PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246433455
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $6,273.80 02/07/2025 Non-covered Recipient Entity
OREGON MEDICAL RESEARCH CENTER PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246433441
Principal investigator 1 Incyte Corporation $2,335.71 01/28/2025 Non-covered Recipient Entity
OREGON MEDICAL RESEARCH CENTER, PC
TRuE AD1 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis No dispute reported 06/30/2026 1240572996